Still, Dr. Anthony Fauci, the government’s top infectious-disease expert, says he isn’t ready to declare that the nation has turned the corner on COVID-19.
vaccine
Boris Johnson reportedly credits ‘greed’ and ‘capitalism’ for vaccine success, sparking debate
Wealthy countries including the United Kingdom have snapped up billions of vaccine doses while people in poorer countries could be waiting until 2024 to get their shots.
Maine to see big jump in COVID-19 vaccine doses next week
Maine’s allocation will climb from 35,190 doses this week to 45,200 next week, according to federal data
Maine launches vaccination pre-registration site as eligibility expands
Maine residents between the ages of 50 and 59 become eligible for vaccination Tuesday, as the state enters the latest phase of the inoculation campaign.
State move to vaccinate 50- to 60-year-olds ‘compounding the problem’ in Lewiston-Auburn, says Auburn mayor
Supply for the COVID-19 vaccine varies across the state: Lewiston-Auburn needs more while some appointments beyond Androscoggin County going unfilled.
Clinics get ready to begin vaccinating Mainers 50 and older
Maine’s 7-day rolling average of new cases remains above 200, which a state health official said could be due to seasonal patterns but also new variants of the coronavirus.
I got the COVID-19 vaccine. What can I safely do?
People who’ve been vaccinated for COVID-19 can enjoy small gatherings again, but should keep wearing a mask and social distancing in public
Maine speeds vaccinations: Residents 50 and older eligible starting Tuesday, all adults April 19
The accelerated timeline comes as some providers are reporting available appointments and as the state is expecting to see an increase in supply from the federal government.
One-shot Johnson & Johnson COVID-19 vaccine in short supply in Maine
State to begin vaccinating housebound residents next week with Johnson & Johnson product.
EU drug regulator finds no overall link between clots, AstraZeneca vaccine
Numerous European countries had suspended use of the vaccine over the last week amid concerns over blood clots in a few dozen of the millions of people vaccinated with the formula across the continent.